Australia markets closed

Nano-X Imaging Ltd. (NNOX)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
9.71-0.80 (-7.61%)
At close: 04:00PM EDT
9.71 0.00 (0.00%)
After hours: 07:32PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close10.51
Open10.41
Bid9.68 x 1000
Ask9.74 x 400
Day's range9.53 - 10.44
52-week range4.89 - 22.69
Volume1,405,298
Avg. volume4,095,855
Market cap561.03M
Beta (5Y monthly)2.13
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • GlobeNewswire

    Nanox Announces Collaboration with AhealthZ and SCL Science to Enter South Korean Market

    AhealthZ to aid Nanox’s pursuit of local authorizations and licenses for Nanox.ARC in South Korea SCL Science to integrate Nanox’s artificial intelligence solutions in operations PETAH TIKVA, Israel, April 09, 2024 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (NASDAQ: NNOX) (“Nanox” or the “Company”), an innovative medical imaging technology company, today announced a new collaboration to advance the Nanox.ARC 3D imaging system and Nanox artificial intelligence (AI) solutions in Korea with AhealthZ –

  • GlobeNewswire

    Nanox Announces Fourth Quarter of 2023 Financial Results and Provides Business Update

    Nanox Launches Nanox.ARC in United States with Installations Across Five States, Marking a Major Advancement in Medical Imaging Management to host conference call and webcast Monday, April 1, 2024 at 8:30 AM ET PETAH TIKVA, Israel, April 01, 2024 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (NASDAQ: NNOX) (“Nanox” or the “Company”), an innovative medical imaging technology company, today announced results for the fourth quarter ended December 31, 2023 and provided a business update. Fourth Quarter 202

  • GlobeNewswire

    Nanox to Report Fourth Quarter and Fiscal Year 2023 Financial Results on April 1, 2024

    PETAH TIKVA, Israel, March 18, 2024 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (NASDAQ: NNOX) (“Nanox” or the “Company”), an innovative medical imaging technology company, today announced that it will report its financial results for the quarter and fiscal year ended December 31, 2023, before market open on Monday, April 1, 2024. Erez Meltzer, Chief Executive Officer, and Ran Daniel, Chief Financial Officer, will host a conference call to review these results and provide a business update beginning